Sponsor:
Massachusetts General Hospital
Code:
NCT07699445
Conditions
Bipolar Depression Depressed Phase
Obesity & Overweight
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
Lumateperone 42 mg
Brief summary:
Conditions
Bipolar Depression Depressed Phase
Obesity & Overweight
Study ID
NCT07699445
Start date
Sep 9, 2026
Status verified date
Sep, 2026
Completion date
Jul 31, 2028
Anticipated
Primary completion date
Jan 31, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Enrollment
25 participants
Anticipated
Intervention Model
Single group
Primary purpose
Treatment
Arms
experimental: Lumateperone treatment
Interventions
Lumateperone 42 mg
Primary outcome measure
Central contacts
Locations
Massachusetts General Hospital
Recruiting
Boston, Massachusetts, United States, 02114
Contacts
Sponsor
Massachusetts General Hospital
Last update posted
Sep 11, 2026
Last verified
Sep, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-12. This information was provided to ClinicalTrials.gov by Massachusetts General Hospital on 2026-09-11.